glp 1 price reduction GLP-1 Antagonists Increase Plan Drug Spend - What's Next A Heavy Price: The Economic

New research into the science of weight loss has shined a powerful light on the promise of GLP-1 and how it may be leveraged in the body for long-lasting appetite control to promote weight loss

With a rapidly increasing number of GLP-1 drugs already being prescribed for conditions such as type 2 diabetes, obesity and kidney disease, these results suggest these medications could potentially be repurposed to reduce the risk of no-reflow in heart attack patients

1 Patients on concomitant insulin therapies or insulin secretagogues are at a higher risk for this adverse event

If you are switching between weekly medications, you should not administer two medications in the same week